Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices
Clinical trial NCT02596009 · COMPLETED
Trial details
- NCT number
- NCT02596009
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-16
- Primary completion
- 2016-04-29
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.